Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nefrologia. 2012;32(2):228-32. doi: 10.3265/Nefrologia.pre2011.Nov.11112. Epub 2012 Mar 16.

Membranous glomerulonephritis, psoriasis and etanercept. A chance or causal association?

[Article in English, Spanish]

Author information

  • 1Hospital Clínico San Carlos, Madrid, Spain. kiqueflorit@hotmail.com

Abstract

Psoriasis is a cutaneous disease with systemic involvement. Tissue damage is considered to be immune-mediated, and etanercept currently provides effective treatment. Kidney injury arising from this condition has not yet been fully explained in the literature. We present a case of membranous nephropathy with C1q deposits followed by development of psoriasis. In this article we will review the possible association between these conditions and the response to this biological molecule.

PMID:
22421953
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Spanish Society of Nephrology
    Loading ...
    Write to the Help Desk